Rubenstein JH , Laine L.Systematic review: the hepatoxicity of non-steroidal anti-inflammatory drugs. Aliment Pharmacol Ther. 2004;20:373-380.
2.
Fries JF, Miller SR, Spitz PW, Williams CA, Hubert HB, Bloch DAIdentification of patients at risk for gastropathy associated with NSAID use . J Rheumatol. Suppl.1990;20:12-19.
3.
Rostom A., Goldkind L., Laine L.Nonsteroidal anti-inflammatory drugs and hepatic toxicity: a systematic review of randomized controlled trials in arthritis patients. Clin Gastroenterol Hepatol. 2005;3:489-498.
4.
Elkrief L., Chryssostalis A., Moachon L., et al. Severe cholestatic hepatitis associated with a Stephens-Johnson syndrome after taking ibuprofen. Gastroenterol Clin Biol. 2007;31:1043-1045.
5.
Javier Rodriguez-Gonzalez F., Montero JL, Puente J., et al. Orthotopic liver transplantation after subacute liver failure induced by therapeutic doses of ibuprofen. Am J Gastroenterol. 2002;97:2476-2477.
6.
Laurent S., Rahier J., Geubel A., Lerut J., Horsmans Y.Subfulminant hepatitis requiring liver transplantation following ibuprofen overdose. Liver. 2000;20:93-94.
7.
Taghian M., Tran Ta T., Bresson-Hadni S., Menget A., Felix S., Jacquemin E.Acute vanishing bile duct syndrome after ibuprofen therapy in a child. J Pediatr. 2004;145:273-276.
8.
Andrade RJ, Lucena MI, Garcia-Cortes M., Garcia-Ruiz E., Fernandez-Bonilla E., Vasquez L.Chronic hepatitis C, ibuprofen, and liver damage. Am J Gastroenterol . 2002;97:1854-1855.
9.
Kaplowitz N.Idiosyncratic drug hepatotoxicity. Nat Rev Drug Discov. 2005;4:489-499.
10.
Daly AK, Aithal GP, Leathart JB, Swainsbury RA, Dang TS, Day CPGenetic susceptibility to diclofenac-induced hepatoxicity: contribution of UGT2B7, CYP2C8, and ABCC2 genotypes. Gastroenterology. 2007;132:272-281.